↓ Skip to main content

Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study

Overview of attention for article published in Arthritis Research & Therapy, July 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
215 Dimensions

Readers on

mendeley
78 Mendeley